-
Cyient DLM
Parent is discounted less than 30 times its earnings but 93%-subsidiary, whose profit margin is significantly lower, is priced at 60+ multiple!
-
Nexus Select Trust REIT
Asset quality exudes optimism for long term though immediate distribution yield is projected to be lower than listed peers.
-
Mankind Pharma
Will it break the jinx of IPOs priced above 1000 times the face value?
-
Uniparts India
Fundamentals justify IPO valuation though existing shareholders’ negative cost of holding may curb share prospects post lock-in
-
Keystone Realtors
Popular brand notwithstanding, fluctuating past performance, uncertain future prospects and steep IPO valuation dilute attraction.
-
Bikaji Foods
Ultra-high P/E multiple for a depleting profit margin? Boom-time IPO pricing is bound to give bitter taste during market downturn!
-
Prudent Corporate
Group companies’ past violation of regulations and acquisition of business from scam-tainted entity reflect poorly on the promoters
-
LIC
Embedded Value makes the offer attractive but, as private insurers gain market share, what happened to GIC and NIA can happen to LIC sooner or later